New CME program: Strategies for Optimizing Stem Cell Mobilization and Collection tinyurl.com/bqe44v9

Story of the Week:Durable Responses Seen With Anti-PD-1 Antibody tinyurl.com/aghm2tj

CME: Targeting Tumor Angiogenesis to Prevent the Growth of Metastatic Colorectal Cancer tinyurl.com/a4ns5a3

Story of the Week: Allo-HCT for Chemo-Unresponsive Mantle Cell Lymphoma tinyurl.com/b5q76tn

Interview With Dr. Roger Stupp: Past, Present, and Future of Oligodendroglioma Treatment tinyurl.com/a2memdo

Interview With Dr. Yvonne Romero: Proton Pump Inhibitors in Patients With Esophageal Cancers tinyurl.com/a3x79gu

OncologySTAT's Top Stories of 2012! tinyurl.com/aqrfw9k

Commentary From Dr. Maura Dickler: A Synopsis of Key Presentations From San Antonio tinyurl.com/bglfrnq

Story of the Week: Second-Line Ramucirumab for Gastric/GEJ Adenocarcinoma Extends Survival tinyurl.com/aahnkp2

Story of the Week: Selumetinib Promising in Refractory Thyroid Cancer tinyurl.com/b46anod

Story of the Week: R-BAC Effective in Older Mantle-Cell Lymphoma Patients tinyurl.com/acv8nw7

Incorporating NovoTTF Into Treatment of Patients With Glioblastoma: Interview With Dr. Eric Wong tinyurl.com/b5zg7q8

Story of the Week: Kadcyla Wins US FDA Approval for Late-Stage Breast Cancer tinyurl.com/bx5ar42

Story of the Week: NCI Trials Overhaul Eyes Community-Based Biomarker Studies tinyurl.com/a2b5tug

Biweekly XELOX as First-Line Treatment in Metastatic Colorectal Cancer tinyurl.com/b2bxx3c

Colorectal Cancer Subtype Associated With Obesity, Inactivity tinyurl.com/abvaorm

Story of the Week: Cisplatin-Based IP Chemotherapy Associated With Improved Survival in BRCA1+ Ovarian Cancer tinyurl.com/ckkkz2b

As of March 31st, PracticeUpdate will replace OncologySTAT. Register now for uninterrupted access! tinyurl.com/a22xt7l

Time is running out! OncologySTAT is shutting down on March 29th! ACT NOW! Register today at PracticeUpdate.com. tinyurl.com/a22xt7l

OncologySTAT will shut down on Friday. Act now and register on the NEW PracticeUpdate website! tinyurl.com/a22xt7l